Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2007

Open Access 01-12-2007 | Review

Idiopathic (primary) achalasia

Authors: Farnoosh Farrokhi, Michael F Vaezi

Published in: Orphanet Journal of Rare Diseases | Issue 1/2007

Login to get access

Abstract

Idiopathic achalasia is a primary esophageal motor disorder characterized by esophageal aperistalsis and abnormal lower esophageal sphincter (LES) relaxation in response to deglutition. It is a rare disease with an annual incidence of approximately 1/100,000 and a prevalence rate of 1/10,000. The disease can occur at any age, with a similar rate in men and women, but is usually diagnosed between 25 and 60 years. It is characterized predominantly by dysphagia to solids and liquids, bland regurgitation, and chest pain. Weight loss (usually between 5 to 10 kg) is present in most but not in all patients. Heartburn occurs in 27%–42% of achalasia patients. Etiology is unknown. Some familial cases have been reported, but the rarity of familial occurrence does not support the hypothesis that genetic inheritance is a significant etiologic factor. Association of achalasia with viral infections and auto-antibodies against myenteric plexus has been reported, but the causal relationship remains unclear. The diagnosis is based on history of the disease, radiography (barium esophagogram), and esophageal motility testing (esophageal manometry). Endoscopic examination is important to rule out malignancy as the cause of achalasia. Treatment is strictly palliative. Current medical and surgical therapeutic options (pneumatic dilation, surgical myotomy, and pharmacologic agents) aimed at reducing the LES pressure and facilitating esophageal emptying by gravity and hydrostatic pressure of retained food and liquids. Although it cannot be permanently cured, excellent palliation is available in over 90% of patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vaezi MF: Achalasia: diagnosis and management. Semin Gastrointest Dis. 1999, 10: 103-112.PubMed Vaezi MF: Achalasia: diagnosis and management. Semin Gastrointest Dis. 1999, 10: 103-112.PubMed
2.
go back to reference Vaezi MF, Richter JE, Wilcox CM, Schroeder PL, Birgisson S, Slaughter RL, Koehler RE, Baker ME: Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut. 1999, 44: 231-239.PubMedCentralCrossRefPubMed Vaezi MF, Richter JE, Wilcox CM, Schroeder PL, Birgisson S, Slaughter RL, Koehler RE, Baker ME: Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut. 1999, 44: 231-239.PubMedCentralCrossRefPubMed
3.
go back to reference Park W, Vaezi MF: Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol. 2005, 100: 1404-1414. 10.1111/j.1572-0241.2005.41775.x.CrossRefPubMed Park W, Vaezi MF: Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol. 2005, 100: 1404-1414. 10.1111/j.1572-0241.2005.41775.x.CrossRefPubMed
4.
go back to reference Mikaeli J, Farrokhi F, Bishehsari F, Mahdavinia M, Malekzadeh R: Gender effect on clinical features of achalasia: a prospective study. BMC Gastroenterol. 2006, 1 (6): 12-12. 10.1186/1471-230X-6-12.CrossRef Mikaeli J, Farrokhi F, Bishehsari F, Mahdavinia M, Malekzadeh R: Gender effect on clinical features of achalasia: a prospective study. BMC Gastroenterol. 2006, 1 (6): 12-12. 10.1186/1471-230X-6-12.CrossRef
5.
go back to reference Vela MF, Vaezi MF: Cost-assessment of alternative management strategies for achalasia. Expert Opin Pharmacother. 2003, 4: 2019-2025. 10.1517/14656566.4.11.2019.CrossRefPubMed Vela MF, Vaezi MF: Cost-assessment of alternative management strategies for achalasia. Expert Opin Pharmacother. 2003, 4: 2019-2025. 10.1517/14656566.4.11.2019.CrossRefPubMed
6.
go back to reference Birgisson S, Richter JE: Achalasia: what's new in diagnosis and treatment?. Dig Dis. 1997, 15 (Suppl 1): 1-27.CrossRefPubMed Birgisson S, Richter JE: Achalasia: what's new in diagnosis and treatment?. Dig Dis. 1997, 15 (Suppl 1): 1-27.CrossRefPubMed
7.
go back to reference Prakash C, Clouse RE: Esophageal motor disorders. Curr Opin Gastroenterol. 1999, 15: 339-10.1097/00001574-199907000-00012.CrossRefPubMed Prakash C, Clouse RE: Esophageal motor disorders. Curr Opin Gastroenterol. 1999, 15: 339-10.1097/00001574-199907000-00012.CrossRefPubMed
8.
9.
go back to reference Richter JE: Modern management of achalasia. Curr Treat Options Gastroenterol. 2005, 8: 275-283. 10.1007/s11938-005-0020-1.CrossRefPubMed Richter JE: Modern management of achalasia. Curr Treat Options Gastroenterol. 2005, 8: 275-283. 10.1007/s11938-005-0020-1.CrossRefPubMed
10.
11.
go back to reference Guardino JM, Vela MF, Connor JT, Richter JE: Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J Clin Gastroenterol. 2004, 38: 855-860. 10.1097/00004836-200411000-00004.CrossRefPubMed Guardino JM, Vela MF, Connor JT, Richter JE: Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J Clin Gastroenterol. 2004, 38: 855-860. 10.1097/00004836-200411000-00004.CrossRefPubMed
12.
go back to reference Vaezi MF, Baker ME, Achkar E, Richter JE: Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut. 2002, 50: 765-770. 10.1136/gut.50.6.765.PubMedCentralCrossRefPubMed Vaezi MF, Baker ME, Achkar E, Richter JE: Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut. 2002, 50: 765-770. 10.1136/gut.50.6.765.PubMedCentralCrossRefPubMed
13.
go back to reference Vaezi MF, Richter JE: Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol. 1998, 27: 21-35. 10.1097/00004836-199807000-00006.CrossRefPubMed Vaezi MF, Richter JE: Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol. 1998, 27: 21-35. 10.1097/00004836-199807000-00006.CrossRefPubMed
14.
go back to reference Clouse RE, Abramson BK, Todorczuk JR: Achalasia in the elderly. Effects of aging on clinical presentation and outcome. Dig Dis Sci. 1991, 36: 225-228. 10.1007/BF01300761.CrossRefPubMed Clouse RE, Abramson BK, Todorczuk JR: Achalasia in the elderly. Effects of aging on clinical presentation and outcome. Dig Dis Sci. 1991, 36: 225-228. 10.1007/BF01300761.CrossRefPubMed
15.
go back to reference d'Alteroche L, Oung C, Fourquet F, Picon L, Lagasse JP, Metman EH: Evolution of clinical and radiological features at diagnosis of achalasia during a 19-year period in central France. Eur J Gastroenterol Hepatol. 2001, 13: 121-126. 10.1097/00042737-200102000-00006.CrossRefPubMed d'Alteroche L, Oung C, Fourquet F, Picon L, Lagasse JP, Metman EH: Evolution of clinical and radiological features at diagnosis of achalasia during a 19-year period in central France. Eur J Gastroenterol Hepatol. 2001, 13: 121-126. 10.1097/00042737-200102000-00006.CrossRefPubMed
16.
go back to reference Rakita S, Bloomston M, Villadolid D, Thometz D, Boe B, Rosemurgy A: Age affects presenting symptoms of achalasia and outcomes after myotomy. Am Surg. 2005, 71: 424-429.PubMed Rakita S, Bloomston M, Villadolid D, Thometz D, Boe B, Rosemurgy A: Age affects presenting symptoms of achalasia and outcomes after myotomy. Am Surg. 2005, 71: 424-429.PubMed
17.
18.
go back to reference Sandler RS, Nyren O, Ekbom A, Eisen GM, Yuen J, Josefsson S: The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA. 1995, 274: 1359-1362. 10.1001/jama.274.17.1359.CrossRefPubMed Sandler RS, Nyren O, Ekbom A, Eisen GM, Yuen J, Josefsson S: The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA. 1995, 274: 1359-1362. 10.1001/jama.274.17.1359.CrossRefPubMed
19.
go back to reference Mearin F, Mourelle M, Guarner F, Salas A, Riveros-Moreno V, Moncada S, Malagelada JR: Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest. 1993, 23: 724-728.CrossRefPubMed Mearin F, Mourelle M, Guarner F, Salas A, Riveros-Moreno V, Moncada S, Malagelada JR: Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest. 1993, 23: 724-728.CrossRefPubMed
20.
go back to reference CASSELLA RR, BROWN AL, SAYRE GP, ELLIS FH: ACHALASIA OF THE ESOPHAGUS: PATHOLOGIC AND ETIOLOGIC CONSIDERATIONS. Ann Surg. 1964, 160 (): 474-487. 10.1097/00000658-196409000-00010.PubMedCentralCrossRefPubMed CASSELLA RR, BROWN AL, SAYRE GP, ELLIS FH: ACHALASIA OF THE ESOPHAGUS: PATHOLOGIC AND ETIOLOGIC CONSIDERATIONS. Ann Surg. 1964, 160 (): 474-487. 10.1097/00000658-196409000-00010.PubMedCentralCrossRefPubMed
21.
go back to reference Higgs B, Kerr FW, ELLIS FH: The experimental production of esophageal achalasia by electrolytic lesions in the medulla. J Thorac Cardiovasc Surg. 1965, 50: 613-625.PubMed Higgs B, Kerr FW, ELLIS FH: The experimental production of esophageal achalasia by electrolytic lesions in the medulla. J Thorac Cardiovasc Surg. 1965, 50: 613-625.PubMed
22.
go back to reference Atkinson M, Ogilvie AL, Robertson CS, Smart HL: Vagal function in achalasia of the cardia. Q J Med. 1987, 63: 297-303.PubMed Atkinson M, Ogilvie AL, Robertson CS, Smart HL: Vagal function in achalasia of the cardia. Q J Med. 1987, 63: 297-303.PubMed
23.
go back to reference Eckardt VF, Krause J, Bolle D: Gastrointestinal transit and gastric acid secretion in patients with achalasia. Dig Dis Sci. 1989, 34: 665-671. 10.1007/BF01540335.CrossRefPubMed Eckardt VF, Krause J, Bolle D: Gastrointestinal transit and gastric acid secretion in patients with achalasia. Dig Dis Sci. 1989, 34: 665-671. 10.1007/BF01540335.CrossRefPubMed
24.
go back to reference Khajanchee YS, VanAndel R, Jobe BA, Barra MJ, Hansen PD, Swanstrom LL: Electrical stimulation of the vagus nerve restores motility in an animal model of achalasia. J Gastrointest Surg. 2003, 7: 843-849.CrossRefPubMed Khajanchee YS, VanAndel R, Jobe BA, Barra MJ, Hansen PD, Swanstrom LL: Electrical stimulation of the vagus nerve restores motility in an animal model of achalasia. J Gastrointest Surg. 2003, 7: 843-849.CrossRefPubMed
25.
go back to reference Holloway RH, Dodds WJ, Helm JF, Hogan WJ, Dent J, Arndorfer RC: Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology. 1986, 90: 924-929.PubMed Holloway RH, Dodds WJ, Helm JF, Hogan WJ, Dent J, Arndorfer RC: Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology. 1986, 90: 924-929.PubMed
26.
go back to reference Greaves RR, Mulcahy HE, Patchett SE, Gorard DA, Fairclough PD, Alstead EM, Farthing MJ: Early experience with intrasphincteric botulinum toxin in the treatment of achalasia. Aliment Pharmacol Ther. 1999, 13: 1221-1225. 10.1046/j.1365-2036.1999.00609.x.CrossRefPubMed Greaves RR, Mulcahy HE, Patchett SE, Gorard DA, Fairclough PD, Alstead EM, Farthing MJ: Early experience with intrasphincteric botulinum toxin in the treatment of achalasia. Aliment Pharmacol Ther. 1999, 13: 1221-1225. 10.1046/j.1365-2036.1999.00609.x.CrossRefPubMed
27.
go back to reference Dodds WJ, Dent J, Hogan WJ, Patel GK, Toouli J, Arndorfer RC: Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology. 1981, 80: 327-333.PubMed Dodds WJ, Dent J, Hogan WJ, Patel GK, Toouli J, Arndorfer RC: Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology. 1981, 80: 327-333.PubMed
28.
go back to reference Goldblum JR, Whyte RI, Orringer MB, Appelman HD: Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol. 1994, 18: 327-337.CrossRefPubMed Goldblum JR, Whyte RI, Orringer MB, Appelman HD: Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol. 1994, 18: 327-337.CrossRefPubMed
29.
go back to reference Goldblum JR, Rice TW, Richter JE: Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology. 1996, 111: 648-654. 10.1053/gast.1996.v111.pm8780569.CrossRefPubMed Goldblum JR, Rice TW, Richter JE: Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology. 1996, 111: 648-654. 10.1053/gast.1996.v111.pm8780569.CrossRefPubMed
30.
go back to reference Frieling T, Berges W, Borchard F, Lubke HJ, Enck P, Wienbeck M: Family occurrence of achalasia and diffuse spasm of the oesophagus. Gut. 1988, 29: 1595-1602. 10.1136/gut.29.11.1595.PubMedCentralCrossRefPubMed Frieling T, Berges W, Borchard F, Lubke HJ, Enck P, Wienbeck M: Family occurrence of achalasia and diffuse spasm of the oesophagus. Gut. 1988, 29: 1595-1602. 10.1136/gut.29.11.1595.PubMedCentralCrossRefPubMed
31.
go back to reference Stein DT, Knauer CM: Achalasia in monozygotic twins. Dig Dis Sci. 1982, 27: 636-640. 10.1007/BF01297220.CrossRefPubMed Stein DT, Knauer CM: Achalasia in monozygotic twins. Dig Dis Sci. 1982, 27: 636-640. 10.1007/BF01297220.CrossRefPubMed
32.
go back to reference Annese V, Napolitano G, Minervini MM, Perri F, Ciavarella G, Di Giorgio G, Andriulli A: Family occurrence of achalasia. J Clin Gastroenterol. 1995, 20: 329-330. 10.1097/00004836-199506000-00016.CrossRefPubMed Annese V, Napolitano G, Minervini MM, Perri F, Ciavarella G, Di Giorgio G, Andriulli A: Family occurrence of achalasia. J Clin Gastroenterol. 1995, 20: 329-330. 10.1097/00004836-199506000-00016.CrossRefPubMed
33.
go back to reference Bosher LP, Shaw A: Achalasia in siblings. Clinical and genetic aspects. Am J Dis Child. 1981, 135: 709-710.CrossRefPubMed Bosher LP, Shaw A: Achalasia in siblings. Clinical and genetic aspects. Am J Dis Child. 1981, 135: 709-710.CrossRefPubMed
34.
go back to reference Jones DB, Mayberry JF, Rhodes J, Munro J: Preliminary report of an association between measles virus and achalasia. J Clin Pathol. 1983, 36: 655-657. 10.1136/jcp.36.6.655.PubMedCentralCrossRefPubMed Jones DB, Mayberry JF, Rhodes J, Munro J: Preliminary report of an association between measles virus and achalasia. J Clin Pathol. 1983, 36: 655-657. 10.1136/jcp.36.6.655.PubMedCentralCrossRefPubMed
35.
go back to reference Robertson CS, Martin BA, Atkinson M: Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut. 1993, 34: 299-302. 10.1136/gut.34.3.299.PubMedCentralCrossRefPubMed Robertson CS, Martin BA, Atkinson M: Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut. 1993, 34: 299-302. 10.1136/gut.34.3.299.PubMedCentralCrossRefPubMed
36.
go back to reference Niwamoto H, Okamoto E, Fujimoto J, Takeuchi M, Furuyama J, Yamamoto Y: Are human herpes viruses or measles virus associated with esophageal achalasia?. Dig Dis Sci. 1995, 40: 859-864. 10.1007/BF02064992.CrossRefPubMed Niwamoto H, Okamoto E, Fujimoto J, Takeuchi M, Furuyama J, Yamamoto Y: Are human herpes viruses or measles virus associated with esophageal achalasia?. Dig Dis Sci. 1995, 40: 859-864. 10.1007/BF02064992.CrossRefPubMed
37.
go back to reference Birgisson S, Galinski MS, Goldblum JR, Rice TW, Richter JE: Achalasia is not associated with measles or known herpes and human papilloma viruses. Dig Dis Sci. 1997, 42: 300-306. 10.1023/A:1018805600276.CrossRefPubMed Birgisson S, Galinski MS, Goldblum JR, Rice TW, Richter JE: Achalasia is not associated with measles or known herpes and human papilloma viruses. Dig Dis Sci. 1997, 42: 300-306. 10.1023/A:1018805600276.CrossRefPubMed
38.
go back to reference Storch WB, Eckardt VF, Wienbeck M, Eberl T, Auer PG, Hecker A, Junginger T, Bosseckert H: Autoantibodies to Auerbach's plexus in achalasia. Cell Mol Biol (Noisy -le-grand). 1995, 41: 1033-1038. Storch WB, Eckardt VF, Wienbeck M, Eberl T, Auer PG, Hecker A, Junginger T, Bosseckert H: Autoantibodies to Auerbach's plexus in achalasia. Cell Mol Biol (Noisy -le-grand). 1995, 41: 1033-1038.
39.
go back to reference Verne GN, Sallustio JE, Eaker EY: Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Dig Dis Sci. 1997, 42: 307-313. 10.1023/A:1018857617115.CrossRefPubMed Verne GN, Sallustio JE, Eaker EY: Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Dig Dis Sci. 1997, 42: 307-313. 10.1023/A:1018857617115.CrossRefPubMed
40.
go back to reference Moses PL, Ellis LM, Anees MR, Ho W, Rothstein RI, Meddings JB, Sharkey KA, Mawe GM: Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut. 2003, 52: 629-636. 10.1136/gut.52.5.629.PubMedCentralCrossRefPubMed Moses PL, Ellis LM, Anees MR, Ho W, Rothstein RI, Meddings JB, Sharkey KA, Mawe GM: Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut. 2003, 52: 629-636. 10.1136/gut.52.5.629.PubMedCentralCrossRefPubMed
41.
go back to reference Raymond L, Lach B, Shamji FM: Inflammatory aetiology of primary oesophageal achalasia: an immunohistochemical and ultrastructural study of Auerbach's plexus. Histopathology. 1999, 35: 445-453. 10.1046/j.1365-2559.1999.035005445.x.CrossRefPubMed Raymond L, Lach B, Shamji FM: Inflammatory aetiology of primary oesophageal achalasia: an immunohistochemical and ultrastructural study of Auerbach's plexus. Histopathology. 1999, 35: 445-453. 10.1046/j.1365-2559.1999.035005445.x.CrossRefPubMed
42.
go back to reference Clark SB, Rice TW, Tubbs RR, Richter JE, Goldblum JR: The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol. 2000, 24: 1153-1158. 10.1097/00000478-200008000-00014.CrossRefPubMed Clark SB, Rice TW, Tubbs RR, Richter JE, Goldblum JR: The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol. 2000, 24: 1153-1158. 10.1097/00000478-200008000-00014.CrossRefPubMed
43.
go back to reference Wong RK, Maydonovitch CL, Metz SJ, Baker JR: Significant DQw1 association in achalasia. Dig Dis Sci. 1989, 34: 349-352. 10.1007/BF01536254.CrossRefPubMed Wong RK, Maydonovitch CL, Metz SJ, Baker JR: Significant DQw1 association in achalasia. Dig Dis Sci. 1989, 34: 349-352. 10.1007/BF01536254.CrossRefPubMed
44.
go back to reference De la Concha EG, Fernandez-Arquero M, Mendoza JL, Conejero L, Figueredo MA, Perez S, Diaz-Rubio M, Ruiz L: Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens. 1998, 52: 381-384.CrossRefPubMed De la Concha EG, Fernandez-Arquero M, Mendoza JL, Conejero L, Figueredo MA, Perez S, Diaz-Rubio M, Ruiz L: Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens. 1998, 52: 381-384.CrossRefPubMed
45.
go back to reference Verne GN, Hahn AB, Pineau BC, Hoffman BJ, Wojciechowski BW, Wu WC: Association of HLA-DR and -DQ alleles with idiopathic achalasia. Gastroenterology. 1999, 117: 26-31. 10.1016/S0016-5085(99)70546-9.CrossRefPubMed Verne GN, Hahn AB, Pineau BC, Hoffman BJ, Wojciechowski BW, Wu WC: Association of HLA-DR and -DQ alleles with idiopathic achalasia. Gastroenterology. 1999, 117: 26-31. 10.1016/S0016-5085(99)70546-9.CrossRefPubMed
46.
go back to reference Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, Fernandez AM, Perez-de-la-Serna J, Gonzalez VA, Rey E, Figueredo A, Diaz-Rubio M, De la Concha EG: Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci. 2002, 47: 15-19. 10.1023/A:1013242831900.CrossRefPubMed Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, Fernandez AM, Perez-de-la-Serna J, Gonzalez VA, Rey E, Figueredo A, Diaz-Rubio M, De la Concha EG: Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci. 2002, 47: 15-19. 10.1023/A:1013242831900.CrossRefPubMed
47.
go back to reference Vantrappen G, VANGOIDSENHOVEN GE, VERBEKE S, VANDENBERGHE G, VANDERBROUCKE J: MANOMETRIC STUDIES IN ACHALASIA OF THE CARDIA, BEFORE AND AFTER PNEUMATIC DILATIONS. Gastroenterology. 1963, 45: 317-325.PubMed Vantrappen G, VANGOIDSENHOVEN GE, VERBEKE S, VANDENBERGHE G, VANDERBROUCKE J: MANOMETRIC STUDIES IN ACHALASIA OF THE CARDIA, BEFORE AND AFTER PNEUMATIC DILATIONS. Gastroenterology. 1963, 45: 317-325.PubMed
48.
go back to reference Camacho-Lobato L, Katz PO, Eveland J, Vela M, Castell DO: Vigorous achalasia: original description requires minor change. J Clin Gastroenterol. 2001, 33: 375-377. 10.1097/00004836-200111000-00006.CrossRefPubMed Camacho-Lobato L, Katz PO, Eveland J, Vela M, Castell DO: Vigorous achalasia: original description requires minor change. J Clin Gastroenterol. 2001, 33: 375-377. 10.1097/00004836-200111000-00006.CrossRefPubMed
49.
go back to reference Vantrappen G, Hellemans J, Deloof W, Valembois P, Vandenbroucke J: Treatment of achalasia with pneumatic dilatations. Gut. 1971, 12: 268-275. 10.1136/gut.12.4.268.PubMedCentralCrossRefPubMed Vantrappen G, Hellemans J, Deloof W, Valembois P, Vandenbroucke J: Treatment of achalasia with pneumatic dilatations. Gut. 1971, 12: 268-275. 10.1136/gut.12.4.268.PubMedCentralCrossRefPubMed
50.
go back to reference de Oliveira JM, Birgisson S, Doinoff C, Einstein D, Herts B, Davros W, Obuchowski N, Koehler RE, Richter J, Baker ME: Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR Am J Roentgenol. 1997, 169: 473-479.CrossRefPubMed de Oliveira JM, Birgisson S, Doinoff C, Einstein D, Herts B, Davros W, Obuchowski N, Koehler RE, Richter J, Baker ME: Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR Am J Roentgenol. 1997, 169: 473-479.CrossRefPubMed
51.
go back to reference Pehlivanov N, Pasricha PJ: Achalasia: botox, dilatation or laparoscopic surgery in 2006. Neurogastroenterol Motil. 2006, 18: 799-804. 10.1111/j.1365-2982.2006.00802.x.CrossRefPubMed Pehlivanov N, Pasricha PJ: Achalasia: botox, dilatation or laparoscopic surgery in 2006. Neurogastroenterol Motil. 2006, 18: 799-804. 10.1111/j.1365-2982.2006.00802.x.CrossRefPubMed
52.
go back to reference Gelfond M, Rozen P, Gilat T: Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology. 1982, 83: 963-969.PubMed Gelfond M, Rozen P, Gilat T: Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology. 1982, 83: 963-969.PubMed
53.
go back to reference Bortolotti M, Coccia G, Brunelli F, Sarti P, Mazza M, Bagnato F, Barbara L: Isosorbide dinitrate or nifedipine: which is preferable in the medical therapy of achalasia?. Ital J Gastroenterol. 1994, 26: 379-382.PubMed Bortolotti M, Coccia G, Brunelli F, Sarti P, Mazza M, Bagnato F, Barbara L: Isosorbide dinitrate or nifedipine: which is preferable in the medical therapy of achalasia?. Ital J Gastroenterol. 1994, 26: 379-382.PubMed
54.
go back to reference Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN: Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med. 1994, 121: 590-591.CrossRefPubMed Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN: Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med. 1994, 121: 590-591.CrossRefPubMed
55.
go back to reference Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN: Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med. 1995, 332: 774-778. 10.1056/NEJM199503233321203.CrossRefPubMed Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN: Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med. 1995, 332: 774-778. 10.1056/NEJM199503233321203.CrossRefPubMed
56.
go back to reference Fishman VM, Parkman HP, Schiano TD, Hills C, Dabezies MA, Cohen S, Fisher RS, Miller LS: Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol. 1996, 91: 1724-1730.PubMed Fishman VM, Parkman HP, Schiano TD, Hills C, Dabezies MA, Cohen S, Fisher RS, Miller LS: Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol. 1996, 91: 1724-1730.PubMed
57.
go back to reference Annese V, Bassotti G, Coccia G, Dinelli M, D'Onofrio V, Gatto G, Leandro G, Repici A, Testoni PA, Andriulli A: A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut. 2000, 46: 597-600. 10.1136/gut.46.5.597.PubMedCentralCrossRefPubMed Annese V, Bassotti G, Coccia G, Dinelli M, D'Onofrio V, Gatto G, Leandro G, Repici A, Testoni PA, Andriulli A: A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut. 2000, 46: 597-600. 10.1136/gut.46.5.597.PubMedCentralCrossRefPubMed
58.
go back to reference Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN: Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology. 1996, 110: 1410-1415. 10.1053/gast.1996.v110.pm8613045.CrossRefPubMed Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN: Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology. 1996, 110: 1410-1415. 10.1053/gast.1996.v110.pm8613045.CrossRefPubMed
59.
go back to reference Eckardt VF, Aignherr C, Bernhard G: Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992, 103: 1732-1738.PubMed Eckardt VF, Aignherr C, Bernhard G: Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992, 103: 1732-1738.PubMed
60.
go back to reference Eckardt VF, Gockel I, Bernhard G: Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut. 2004, 53: 629-633. 10.1136/gut.2003.029298.PubMedCentralCrossRefPubMed Eckardt VF, Gockel I, Bernhard G: Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut. 2004, 53: 629-633. 10.1136/gut.2003.029298.PubMedCentralCrossRefPubMed
61.
go back to reference Torbey CF, Achkar E, Rice TW, Baker M, Richter JE: Long-term outcome of achalasia treatment: the need for closer follow-up. J Clin Gastroenterol. 1999, 28: 125-130. 10.1097/00004836-199903000-00008.CrossRefPubMed Torbey CF, Achkar E, Rice TW, Baker M, Richter JE: Long-term outcome of achalasia treatment: the need for closer follow-up. J Clin Gastroenterol. 1999, 28: 125-130. 10.1097/00004836-199903000-00008.CrossRefPubMed
62.
go back to reference Karamanolis G, Sgouros S, Karatzias G, Papadopoulou E, Vasiliadis K, Stefanidis G, Mantides A: Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol. 2005, 100: 270-274. 10.1111/j.1572-0241.2005.40093.x.CrossRefPubMed Karamanolis G, Sgouros S, Karatzias G, Papadopoulou E, Vasiliadis K, Stefanidis G, Mantides A: Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol. 2005, 100: 270-274. 10.1111/j.1572-0241.2005.40093.x.CrossRefPubMed
63.
go back to reference Farhoomand K, Connor JT, Richter JE, Achkar E, Vaezi MF: Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol. 2004, 2: 389-394. 10.1016/S1542-3565(04)00123-5.CrossRefPubMed Farhoomand K, Connor JT, Richter JE, Achkar E, Vaezi MF: Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol. 2004, 2: 389-394. 10.1016/S1542-3565(04)00123-5.CrossRefPubMed
64.
go back to reference Vela MF, Richter JE, Khandwala F, Blackstone EH, Wachsberger D, Baker ME, Rice TW: The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006, 4: 580-587. 10.1016/S1542-3565(05)00986-9.CrossRefPubMed Vela MF, Richter JE, Khandwala F, Blackstone EH, Wachsberger D, Baker ME, Rice TW: The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006, 4: 580-587. 10.1016/S1542-3565(05)00986-9.CrossRefPubMed
65.
go back to reference Marshall JB, Bodnarchuk G, Singh A: Supine and upright radionuclide esophageal transit before and after treatment for achalasia. Clin Nucl Med. 1994, 19: 683-686. 10.1097/00003072-199408000-00007.CrossRefPubMed Marshall JB, Bodnarchuk G, Singh A: Supine and upright radionuclide esophageal transit before and after treatment for achalasia. Clin Nucl Med. 1994, 19: 683-686. 10.1097/00003072-199408000-00007.CrossRefPubMed
66.
go back to reference Kim CH, Cameron AJ, Hsu JJ, Talley NJ, Trastek VF, Pairolero PC, O'Connor MK, Colwell LJ, Zinsmeister AR: Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation. Mayo Clin Proc. 1993, 68: 1067-1073.CrossRefPubMed Kim CH, Cameron AJ, Hsu JJ, Talley NJ, Trastek VF, Pairolero PC, O'Connor MK, Colwell LJ, Zinsmeister AR: Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation. Mayo Clin Proc. 1993, 68: 1067-1073.CrossRefPubMed
67.
go back to reference Gross R, Johnson LF, Kaminski RJ: Esophageal emptying in achalasia quantitated by a radioisotope technique. Dig Dis Sci. 1979, 24: 945-949. 10.1007/BF01311951.CrossRefPubMed Gross R, Johnson LF, Kaminski RJ: Esophageal emptying in achalasia quantitated by a radioisotope technique. Dig Dis Sci. 1979, 24: 945-949. 10.1007/BF01311951.CrossRefPubMed
68.
go back to reference Vaezi MF, Baker ME, Richter JE: Assessment of esophageal emptying post-pneumatic dilation: use of the timed barium esophagram. Am J Gastroenterol. 1999, 94: 1802-1807. 10.1111/j.1572-0241.1999.01209.x.CrossRefPubMed Vaezi MF, Baker ME, Richter JE: Assessment of esophageal emptying post-pneumatic dilation: use of the timed barium esophagram. Am J Gastroenterol. 1999, 94: 1802-1807. 10.1111/j.1572-0241.1999.01209.x.CrossRefPubMed
69.
go back to reference Vaezi MF: Quantitative methods to determine efficacy of treatment in achalasia. Gastrointest Endosc Clin N Am. 2001, 11: 409-4ix.PubMed Vaezi MF: Quantitative methods to determine efficacy of treatment in achalasia. Gastrointest Endosc Clin N Am. 2001, 11: 409-4ix.PubMed
70.
71.
go back to reference Annese V, Basciani M, Perri F, Lombardi G, Frusciante V, Simone P, Andriulli A, Vantrappen G: Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology. 1996, 111: 1418-1424. 10.1016/S0016-5085(96)70002-1.CrossRefPubMed Annese V, Basciani M, Perri F, Lombardi G, Frusciante V, Simone P, Andriulli A, Vantrappen G: Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology. 1996, 111: 1418-1424. 10.1016/S0016-5085(96)70002-1.CrossRefPubMed
72.
go back to reference Mikaeli J, Fazel A, Montazeri G, Yaghoobi M, Malekzadeh R: Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther. 2001, 15: 1389-1396. 10.1046/j.1365-2036.2001.01065.x.CrossRefPubMed Mikaeli J, Fazel A, Montazeri G, Yaghoobi M, Malekzadeh R: Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther. 2001, 15: 1389-1396. 10.1046/j.1365-2036.2001.01065.x.CrossRefPubMed
73.
go back to reference O'Connor JB, Singer ME, Imperiale TF, Vaezi MF, Richter JE: The cost-effectiveness of treatment strategies for achalasia. Dig Dis Sci. 2002, 47: 1516-1525. 10.1023/A:1015811001267.CrossRefPubMed O'Connor JB, Singer ME, Imperiale TF, Vaezi MF, Richter JE: The cost-effectiveness of treatment strategies for achalasia. Dig Dis Sci. 2002, 47: 1516-1525. 10.1023/A:1015811001267.CrossRefPubMed
74.
go back to reference Gockel I, Junginger T, Bernhard G, Eckardt VF: Heller myotomy for failed pneumatic dilation in achalasia: how effective is it?. Ann Surg. 2004, 239: 371-377. 10.1097/01.sla.0000114228.34809.01.PubMedCentralCrossRefPubMed Gockel I, Junginger T, Bernhard G, Eckardt VF: Heller myotomy for failed pneumatic dilation in achalasia: how effective is it?. Ann Surg. 2004, 239: 371-377. 10.1097/01.sla.0000114228.34809.01.PubMedCentralCrossRefPubMed
75.
go back to reference Gordon JM, Eaker EY: Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients. Am J Gastroenterol. 1997, 92: 1812-1817.PubMed Gordon JM, Eaker EY: Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients. Am J Gastroenterol. 1997, 92: 1812-1817.PubMed
76.
go back to reference Martinek J, Siroky M, Plottova Z, Bures J, Hep A, Spicak J: Treatment of patients with achalasia with botulinum toxin: a multicenter prospective cohort study. Dis Esophagus. 2003, 16: 204-209. 10.1046/j.1442-2050.2003.00329.x.CrossRefPubMed Martinek J, Siroky M, Plottova Z, Bures J, Hep A, Spicak J: Treatment of patients with achalasia with botulinum toxin: a multicenter prospective cohort study. Dis Esophagus. 2003, 16: 204-209. 10.1046/j.1442-2050.2003.00329.x.CrossRefPubMed
77.
go back to reference Zaninotto G, Annese V, Costantini M, Del Genio A, Costantino M, Epifani M, Gatto G, D'Onofrio V, Benini L, Contini S, Molena D, Battaglia G, Tardio B, Andriulli A, Ancona E: Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia. Ann Surg. 2004, 239: 364-370. 10.1097/01.sla.0000114217.52941.c5.PubMedCentralCrossRefPubMed Zaninotto G, Annese V, Costantini M, Del Genio A, Costantino M, Epifani M, Gatto G, D'Onofrio V, Benini L, Contini S, Molena D, Battaglia G, Tardio B, Andriulli A, Ancona E: Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia. Ann Surg. 2004, 239: 364-370. 10.1097/01.sla.0000114217.52941.c5.PubMedCentralCrossRefPubMed
78.
go back to reference Bessell JR, Lally CJ, Schloithe A, Jamieson GG, Devitt PG, Watson DI: Laparoscopic cardiomyotomy for achalasia: long-term outcomes. ANZ J Surg. 2006, 76: 558-562. 10.1111/j.1445-2197.2006.03784.x.CrossRefPubMed Bessell JR, Lally CJ, Schloithe A, Jamieson GG, Devitt PG, Watson DI: Laparoscopic cardiomyotomy for achalasia: long-term outcomes. ANZ J Surg. 2006, 76: 558-562. 10.1111/j.1445-2197.2006.03784.x.CrossRefPubMed
79.
go back to reference Dang Y, Mercer D: Treatment of esophageal achalasia with Heller myotomy: retrospective evaluation of patient satisfaction and disease-specific quality of life. Can J Surg. 2006, 49: 267-271.PubMedCentralPubMed Dang Y, Mercer D: Treatment of esophageal achalasia with Heller myotomy: retrospective evaluation of patient satisfaction and disease-specific quality of life. Can J Surg. 2006, 49: 267-271.PubMedCentralPubMed
80.
go back to reference Raiser F, Perdikis G, Hinder RA, Swanstrom LL, Filipi CJ, McBride PJ, Katada N, Neary PJ: Heller myotomy via minimal-access surgery. An evaluation of antireflux procedures. Arch Surg. 1996, 131: 593-597.CrossRefPubMed Raiser F, Perdikis G, Hinder RA, Swanstrom LL, Filipi CJ, McBride PJ, Katada N, Neary PJ: Heller myotomy via minimal-access surgery. An evaluation of antireflux procedures. Arch Surg. 1996, 131: 593-597.CrossRefPubMed
81.
go back to reference Hunt DR, Wills VL: Laparoscopic Heller myotomy for achalasia. Aust N Z J Surg. 2000, 70: 582-586. 10.1046/j.1440-1622.2000.01903.x.CrossRefPubMed Hunt DR, Wills VL: Laparoscopic Heller myotomy for achalasia. Aust N Z J Surg. 2000, 70: 582-586. 10.1046/j.1440-1622.2000.01903.x.CrossRefPubMed
82.
go back to reference Frantzides CT, Moore RE, Carlson MA, Madan AK, Zografakis JG, Keshavarzian A, Smith C: Minimally invasive surgery for achalasia: a 10-year experience. J Gastrointest Surg. 2004, 8: 18-23. 10.1016/j.gassur.2003.09.021.CrossRefPubMed Frantzides CT, Moore RE, Carlson MA, Madan AK, Zografakis JG, Keshavarzian A, Smith C: Minimally invasive surgery for achalasia: a 10-year experience. J Gastrointest Surg. 2004, 8: 18-23. 10.1016/j.gassur.2003.09.021.CrossRefPubMed
83.
go back to reference Zaninotto G, Costantini M, Molena D, Buin F, Carta A, Nicoletti L, Ancona E: Treatment of esophageal achalasia with laparoscopic Heller myotomy and Dor partial anterior fundoplication: prospective evaluation of 100 consecutive patients. J Gastrointest Surg. 2000, 4: 282-289. 10.1016/S1091-255X(00)80077-3.CrossRefPubMed Zaninotto G, Costantini M, Molena D, Buin F, Carta A, Nicoletti L, Ancona E: Treatment of esophageal achalasia with laparoscopic Heller myotomy and Dor partial anterior fundoplication: prospective evaluation of 100 consecutive patients. J Gastrointest Surg. 2000, 4: 282-289. 10.1016/S1091-255X(00)80077-3.CrossRefPubMed
Metadata
Title
Idiopathic (primary) achalasia
Authors
Farnoosh Farrokhi
Michael F Vaezi
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2007
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-2-38

Other articles of this Issue 1/2007

Orphanet Journal of Rare Diseases 1/2007 Go to the issue